ArticleFrontiers in pharmacology2018

c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism.

Yu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.